CLRO

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 2.31 M1.92 M0-4.23 M0 -2.31 M Gross profit 121 K-231 K-27 K-43 K-70 K -371 K Operating expenses 2.97 M4.33 M827 K-1.89 M780 K 4.05 M Selling/general/admin expenses 2.28 M2.97 M827 K-1.12 M780 K 3.46 M Research & development 691 K1.36 M0—0 — Operating income -2.85 M-4.56 M-854 K1.84 M-850 K -4.42 M Non-Operating Income, Total 12 K3 0004 000-136 K0 -129 K Interest expense, net of interest capitalized 08 00020 K—0 — Non-Operating Income, excl. Interest Expenses 0-8 000-20 K00 -28 K Unusual income/expense 12 K3 0004 000-136 K0 -129 K Pretax income -2.83 M-4.56 M-870 K1.71 M-850 K -4.58 M Equity in earnings ————— — Taxes 08 0001 00074 K0 83 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -2.83 M-1.59 M-871 K-1.35 M-850 K -4.66 M Discontinued operations —-2.98 M-12.87 M-3.6 M363 K -19.08 M Net income -2.83 M-4.57 M-13.74 M-4.94 M-487 K -23.74 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -2.83 M-4.57 M-13.74 M-4.94 M-487 K -23.74 M Basic earnings per share (Basic EPS) -1.65-2.64-7.92-2.5-0.21 -13.27 Diluted earnings per share (Diluted EPS) -1.65-2.64-7.92-2.5-0.18 -13.24 Average basic shares outstanding 1.65 M1.73 M1.73 M1.77 M2.38 M — Diluted shares outstanding 1.65 M1.73 M1.73 M1.77 M2.75 M — EBITDA -2.8 M-4.51 M——— — EBIT -2.85 M-4.56 M-854 K3.86 M-850 K -2.4 M Cost of revenue 2.19 M2.15 M27 K-4.04 M70 K -1.79 M Other cost of goods sold 272 K48 K0—— — Depreciation & amortization (cash flow) 50 K51 K——— —